MARKET

IPSEY

IPSEY

Ipsen Sa
OTCPK
46.70
NaN%
Closed 09:30 07/24 EDT
OPEN
--
PREV CLOSE
46.70
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
50.32
52 WEEK LOW
30.09
MARKET CAP
15.39B
P/E (TTM)
29.92
1D
5D
1M
3M
1Y
5Y
1D
Ipsen phase 3 Bylvay trial in biliary atresia misses primary goal
Seeking Alpha · 1d ago
Weekly Report: what happened at IPSEY last week (0713-0717)?
Weekly Report · 5d ago
Weekly Report: what happened at IPSEY last week (0706-0710)?
Weekly Report · 07/13 10:05
Here's Why Ipsen S.A. Just Paid €700M For Memo Therapeutics AG
Seeking Alpha · 07/10 12:40
Ipsen's Dysport Becomes First Botulinum Toxin To Show Statistically Significant Efficacy In Episodic Migraine, Positioning It As Potential First-In-Class Treatment
Benzinga · 07/09 06:58
Weekly Report: what happened at IPSEY last week (0629-0703)?
Weekly Report · 07/06 10:08
Ipsen to acquire Memo Therapeutics in deal worth over €700M
Seeking Alpha · 07/01 05:24
Weekly Report: what happened at IPSEY last week (0622-0626)?
Weekly Report · 06/29 10:04
More
About IPSEY
Ipsen SA is a France-based biopharmaceutical group specialized in specialty care. The Company operates globally through two segments: Specialty Care and Consumer Healthcare. In Specialty Care, the Company is focused on various therapeutic areas, including oncology, neurosciences and rare diseases. Its oncology portfolio includes Somatuline, Decapeptyl, Cabometyx and Onivyde. Its neuroscience portfolio includes Dysport, and in rare diseases key products are NutropinAq and Increlex. Its primary care portfolio includes Smecta, Forlax, Fortrans, Eziclen, and Tanakan. In oncology Ipsen focuses on a number of disease areas, which include neuroendocrine tumors, renal cell carcinoma, hepatocellular carcinoma and pancreatic cancer. In addition, the Company has specialism in neurotoxin research and operates three research and development centers located in France, the United Kingdom and the United States.

Webull offers Ipsen SA stock information, including OTCPK: IPSEY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IPSEY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IPSEY stock methods without spending real money on the virtual paper trading platform.